Abstract: An assay for detecting type IV cytosolic phospholipase A2(cPLA2) or a protein immunologically homologous to type IV cPLA2, the assay comprising use of red blood cells, particularly for use in the diagnosis of a disease in which dysfunction of cell signalling systems involving highly unsaturated fatty acids is implicated.
Type:
Grant
Filed:
March 8, 2000
Date of Patent:
March 21, 2006
Assignee:
Amarin Neuroscience Limited
Inventors:
Alastair Campbell Agnew Glen, Donald John Mcdonald